2002 Sep 1;101(1):7-10
Model prediction Figure 4 is the efficacy trend from carnitine supplementation on body weight in patients with PCOS, where the treatment times to achieve 25%, 50%, 75%, and 80% (plateau) E max of carnitine supplementation on body weight are 1.2, 3.6, 10.8, and 14.4 weeks, respectively
According to the UK Summary of Product Characteristics (SmPC), the most frequently reported adverse reactions include: Nausea (very common, particularly at higher doses) Diarrhoea and vomiting (common to very common) Decreased appetite (very common) Constipation (common) Abdominal pain or discomfort (common) Dyspepsia (indigestion) (common) These gastrointestinal effects are typically most pronounced when initiating treatment or increasing the dose, and often diminish over time as the body adjusts to the medication
Detailed Images
Eli Lilly, the manufacturer, moved it into phase 3 trials
Simply contact the pharmacy of your choice to initiate transfer, and we will handle the rest